The diagnostic criteria for functional gastrointestinal disorders (FGIDs) are undergoing a revolution, all thanks to an international effort led by the Rome Foundation. These standards not only facilitate the establishment of scientific data, but also bring significant improvements in the diagnosis and treatment of common gastrointestinal disorders such as irritable bowel syndrome and functional dyspepsia.
Historical BackgroundThe evolution of the Rome criteria reveals a historical shift in diagnostic approaches that not only changed how physicians diagnosed these conditions but also influenced treatment options for patients.
Since 1962, efforts to classify functional gastrointestinal disorders have continued to advance. The first classifications came from Oxford, England, when Chaudhary and Truelove identified some important gastrointestinal symptoms. In the following decades, various standards were developed, forming today's Roman classification system.
From the Rome I standard first released in 1994, to the later Rome II and III, and up to the latest Rome IV, these standards continue to absorb new research results. The Rome IV was published in 2016 and covers 33 functional gastrointestinal disorders in adults and 17 in children, systematically integrating clinical, pathological and psychosocial characteristics.
The current Rome IV criteria not only consider symptoms, but also attempt to use a multidimensional clinical profile system to enable scientists to develop personalized treatment plans based on the characteristics of individual patients.
As an independent nonprofit organization, the Roma Foundation plays a key role in advancing the diagnosis and treatment of functional gastrointestinal disorders. Since its founding in 1996, the Foundation has brought together scientists and clinicians to advance scientific understanding of these diseases and provide diagnostic support.
Functional gastrointestinal disorders are a group of diseases characterized by gastrointestinal symptoms, which may involve multiple factors such as motility disorders, visceral allergies, and changes in immune function. The interactive effects of these conditions complicate diagnosis and treatment, especially in the context of the psychosocial environment.
Rome IV changed the diagnostic criteria from physiological to symptom-based, a far-reaching change that gave doctors around the world more flexibility to consider the specific circumstances of their patients when making diagnoses.
Although the Rome criteria have played an important role in updating diagnosis and treatment, certain challenges remain. Symptoms are reported differently across cultures, placing demands on clinical practice around the world. In addition, how to enable clinicians to flexibly apply these standards is also a direction that needs to be worked on in the future.
The Rome Foundation is working to develop an intelligent software platform that will allow clinicians to instantly query diagnostic criteria and make treatment decisions.
With the continuous evolution of the Rome criteria, the diagnostic methods of functional gastrointestinal disorders are gradually improving, which brings hope to countless patients. However, can this revolutionary change truly become universal and improve the quality of life of every patient?